Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001493152-25-018021

10% owner sold 251,360 shares at an average $6.14 ($1,543,899)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

SVF Endurance (Cayman) Ltd · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-09 Sale : show line 1 in the form 10b5-1 −249,060 $6.14 $1,529,926 15,372,309 I
2025-10-10 Sale : show line 2 in the form 10b5-1 −2,300 $6.08 $13,973 15,370,009 I
Open-market sales · 251,360 sh · avg $6.14 · $1,543,899
Loading xslF345X05/ownership.xml…